Loading clinical trials...

Comparison of Elagolix and OCPs in Reducing Endometriosis Associated Pelvic Pain | Clinical Trials | Clareo Health

Enrolling By InvitationPhase 4NCT07532876

Comparison of Elagolix and OCPs in Reducing Endometriosis Associated Pelvic Pain

This study is designed to provide direct evidence on the relative effectiveness and safety of Elagolix versus OCPs, helping physicians make more tailored treatment decisions.

Lead sponsor: Pak Emirates Military Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

UNKNOWN

CellAdhesionMolecule EndometriosisRatio - CAMERA

NCT04294017 · Endometriosis (Diagnosis), Identification of Biomarkers in Serum

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 16, 2026Terms

Trial snapshot

StatusENROLLING_BY_INVITATION

PhasePHASE4

Enrollment90

Start dateMay 2026

Last updatedApr 16, 2026

Condition

Endometriosis (Diagnosis)

Locations shown

Pak Emirates Military Hospital

Rawalpindi, Punjab Province

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 16, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions